Get test results
Make an appointment
Home>Information>Comprehensive offers>Cancer risk 40+ (prostate)

Cancer risk 40+ (prostate)

– Transrectal ultrasound of the prostate: TRUS is necessary to assess the condition of the internal genital organs and determine the presence of prostate cancer.


– Prostate-specific antigen, common and free (tumor marker) This marker must be determined annually as an early indicator of malignant disease of the prostate, which will enable timely radical treatment without the development of metastases.

– Examination and consultation of an andrologist is necessary for the evaluation and interpretation of the data obtained after the studies.